Warning
Fagron Compounding Services Recalls norepinephrine Bitartrate
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0439-2026Drug / Pharmaceutical
Fagron Compounding Services Recalls norepinephrine Bitartrate
Fagron Compounding Services · Class II — Moderate Risk
Product Description
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
Reason for Recall
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the U.S.A.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
Sources: FDA openFDA Enforcement Database